Clinical Pharmacist at Memorial Healthcare System in Tamarac, Florida.
Fidaxomicin Reduces Recurrence Risk in High-Risk C difficile Infections
At MAD-ID, Alyssa Cox, PharmD, showed fidaxomicin reduces 90-day recurrence by 68.3% versus vancomycin, with rates of 7.9% vs. 19% in 176 hospitalized patients.
Read More